J. L. Moore et al. / Tetrahedron 62 (2006) 11477–11482
11481
The reaction mixture was then poured onto a column of
silica gel and eluted with a suitable solution of ethyl acetate
in hexanes to afford analytically pure product.
Rf¼0.36 (7:3 Hex/EtOAc); [a]2D5 +20.6 (CHCl3); HPLC anal-
ysis—Chiracel AD-H column, 97:3 hexanes to isopropanol
1.0 mL/min. Minor enantiomer: 20.0 min, major enantiomer:
22.7 min; 1H NMR (300 MHz, CDCl3) d 7.81 (d, 1H,
J¼7.9 Hz), 7.58 (t, 1H, J¼8.1 Hz), 7.40 (d, 1H, J¼8.1 Hz),
7.25 (m, 1H), 3.69 (s, 3H), 3.64 (s, 3H), 3.53 (d, 1H,
J¼17.3 Hz), 3.11 (d, 1H, J¼17.3 Hz); 13C NMR (100 MHz,
CDCl3) d 196.9, 170.3, 168.5, 151.9, 136.3, 129.7, 127.7,
125.7, 124.1, 62.4, 53.9, 52.4, 39.7; IR (NaCl, neat) 2954,
3.2.2. General procedure for the asymmetric intramole-
cular Stetter reaction of aliphatic substrates. A flame-
dried round bottom flask was charged with triazolium salt
(0.02 mmol, 0.2 equiv) and toluene (1 mL) under argon.
To this solution was added KHMDS (0.5 M in toluene)
(0.02 mmol, 0.2 equiv) via syringe and the solution was
stirred at ambient temperature for 5 min. Substrate
(0.01 mmol, 1 equiv) in toluene was added (1 mL) via
syringe and allowed to stir for 24 h at ambient temperature.
The reaction mixture was then poured onto a column of
silica gel and eluted with a suitable solution of ethyl acetate
in hexanes to afford analytically pure product.
1738, 1705, 1587 cmꢁ1
; HRMS (FAB+) calcd for
C13H13O5S: 281.0484. Found: 281.0480.
3.2.2.5. (R)-(3-Methyl-4-oxo-thiochroman-3-yl)-acetic
acid methyl ester (21). Rf¼0.38 (7:3 Hex/EtOAc); [a]D25
+41.6 (CHCl3); HPLC analysis—Chiracel OD-H column,
90:10 hexanes to isopropanol 0.5 mL/min. Minor enantio-
mer: 8.8 min, major enantiomer: 7.5 min; 1H NMR
(300 MHz, CDCl3) d 8.10 (d, 1H, J¼8.6 Hz), 7.36 (t, 1H,
J¼6.5 Hz), 7.25–7.14 (m, 2H), 4.13 (d, 1H, J¼7.1 Hz),
4.11 (q, 2H, J¼7.1 Hz), 3.74 (d, 1H, J¼13.5 Hz), 3.01 (d,
1H, J¼16.1 Hz), 2.98 (d, 1H, J¼13.5 Hz), 2.56 (d, 1H,
J¼16.1 Hz), 1.40 (s, 3H), 1.23 (t, 3H, J¼7.1 Hz); 13C
NMR (100 MHz, CDCl3) d 196.9, 171.2, 141.4, 133.2,
130.6, 130.0, 127.5, 125.2, 60.8, 43.6, 41.2, 36.6, 21.2,
3.2.2.1. (R)-(3-Oxo-2-propyl-2,3-dihydro-benzo[b]thio-
phen-2-yl)-acetic acid methyl ester (10). Rf¼0.43 (7:3
Hex/EtOAc); [a]2D5 +21.2 (CHCl3); HPLC analysis—Chiracel
OD-H column, 90:10 hexanes to isopropanol 0.5 mL/min.
1
Minor enantiomer: 6.0 min, major enantiomer: 7.5 min; H
NMR (300 MHz, CDCl3) d 7.78 (d, 1H, J¼7.7 Hz), 7.53 (t,
1H, J¼7.9 Hz), 7.37 (d, 1H, J¼7.9 Hz), 7.2 (t, 1H, J¼
7.0 Hz), 3.56 (s, 3H), 3.07 (d, 1H, J¼16.7), 2.96 (d, 1H, J¼
16.7 Hz), 1.86 (ddd, 2H, J¼5.5, 6.8, 9.6 Hz), 1.54–1.35 (m,
1H), 1.26–1.03 (m, 1H), 0.84 (t, 3H, J¼7.3 Hz); 13C NMR
(100 MHz, CDCl3) d 203.9, 170.4, 152.1, 135.7, 131.3,
126.8, 124.9, 124.1, 62.7, 52.0, 42.8, 41.3, 17.9, 14.1; IR
(NaCl, neat) 2958, 1741, 1699, 1591, 1449 cmꢁ1; HRMS
(FAB+) calcd for C14H17O3S: 265.0898. Found: 265.0885.
14.4; IR (NaCl, neat) 2978, 1732, 1676, 1589, 1435 cmꢁ1
;
HRMS (FAB+) calcd for C14H17O3S: 265.0898. Found:
265.0905.
3.2.2.6. (1,1,3,-Trioxo-2-propyl-tetrahydro-1,6-thio-
phene-yl)-acetic acid methyl ester (29). Rf¼0.15 (7:3
1
Hex/EtOAc); [a]2D5 +24.5 (CHCl3); H NMR (300 MHz,
CDCl3) d 3.67 (s, 3H), 3.65 (ddd, 1H, J¼12.5, 11.7,
8.5 Hz), 3.50 (ddd, 1H, J¼12.5, 9.2, 2.4 Hz), 3.17 (d, 1H,
J¼17.9 Hz), 3.11 (ddd, 1H, J¼17.9, 8.5, 2.2 Hz), 3.10 (d,
1H, J¼17.9 Hz), 2.88 (ddd, 1H, J¼17.9, 11.6, 9.1 Hz),
1.87 (ddd, 1H, J¼14.1, 9.3, 7.1 Hz), 1.70 (dm, 1H, J¼
14.1 Hz), 1.48 (ddq, 2H, J¼9.3, 7.1, 7.1 Hz), 0.93 (t, 3H,
J¼7.2 Hz); 13C NMR (100 MHz, CDCl3) d 206.1, 171.4,
65.8, 52.8, 50.7, 39.4, 36.7, 36.3, 17.7, 14.4; IR (NaCl,
neat) 2964, 1732, 1439, 1313 cmꢁ1; HRMS (FAB+) calcd
for C10H16O5S: 248.0718. Found: 248.0705.
3.2.2.2. (R)-(3-Oxo-2-phenethyl-2,3-dihydro-benzo-
[b]thiophen-2-yl)-acetic acid methyl ester (12). Rf¼0.46
(7:3 Hex/EtOAc); [a]D25 ꢁ27.8 (CHCl3); HPLC analysis—
Chiracel OD-H column, 90:10 hexanes to isopropanol
0.5 mL/min. Minor enantiomer: 9.3 min, major enantiomer:
1
11.8 min; H NMR (300 MHz, CDCl3) d 7.82 (d, 1H, J¼
7.8 Hz), 7.57 (t, 1H, J¼6.9 Hz), 7.43 (d, 1H, J¼7.9 Hz),
7.26–7.10 (m, 6H), 3.59 (s, 3H), 3.12 (d, 1H, J¼16.8 Hz),
3.00 (d, 1H, J¼16.8 Hz), 2.79–2.67 (m, 1H), 2.47–2.37
(m, 1H), 2.27–2.19 (m, 2H); 13C NMR (100 MHz, CDCl3)
d 203.3, 170.3, 152.0, 140.92, 136.0, 131.3, 128.6, 126.9,
126.3, 125.1, 124.3, 62.6, 52.2, 43.1, 41.2, 31.0; IR (NaCl,
neat) 2950, 1741, 1699, 1591, 1450 cmꢁ1; HRMS (FAB+)
calcd for C19H19O3S: 327.1055. Found: 327.1048.
3.2.2.7. 1-Acetyl-2-methyl-(2-oxo-propyl)-pyrrolidin-
3-one (31). Rf¼0.21 (9:1 EtOAc/i-PrOH); [a]2D5 ꢁ57.1
(CHCl3); GC analysis—chiraldex BPH column, 120 ꢀC
1.5 mL/min. Minor enantiomer: 46.0 min, major enantio-
1
mer: 46.2 min; H NMR (400 MHz, CDCl3) d 4.14 (dd,
3.2.2.3. (R)-(3-Oxo-2-phenyl-2,3-dihydro-benzo[b]-
thiophen-2-yl)-acetic acid methyl ester (14). Rf¼0.46
(7:3 Hex/EtOAc); [a]D25 ꢁ10.3 (CHCl3); HPLC analysis—
Chiracel OD-H column, 90:10 hexanes to isopropanol
0.5 mL/min. Minor enantiomer: 8.4 min, major enantiomer:
1H, J¼18.6, 0 Hz), 3.82 (ddd, 1H, J¼18.1, 8.9, 8.9 Hz),
3.75 (ddd, 1H, J¼10.2, 10.2, 3.8 Hz), 2.96 (dd, 1H, J¼
18.8, 0 Hz), 2.90 (ddd, 1H, J¼17.9, 9.0, 3.6 Hz), 2.66 (ddd,
1H, J¼18.5, 9.4, 9.4 Hz), 2.03 (s, 3H), 2.01 (s, 3H), 1.36
(s, 3H); 13C NMR (100 MHz, CDCl3) d 214.6, 207.3,
170.6, 64.1, 50.9, 43.9, 29.4, 23.2, 22.2; IR (NaCl, neat)
2915, 1745, 1706, 1634, 1414 cmꢁ1; HRMS (FAB+) calcd
for C10H16NO3, 198.1130. Found 198.1135.
1
6.7 min; H NMR (300 MHz, CDCl3) d 7.70 (d, 1H, J¼
7.9 Hz), 7.44 (t, 2H, J¼8.1 Hz), 7.23–7.11 (m, 6H), 3.73
(s, 3H), 3.63 (d, 1H, J¼14.0 Hz), 3.56 (d, 1H, J¼14.0 Hz);
13C NMR (100 MHz, CDCl3) d 198.1, 169.6, 151.6, 136.1,
134.2, 130.9, 130.1, 128.0, 127.4, 127.2, 125.3, 123.9,
64.6, 53.7, 39.9; IR (NaCl, neat) 2952, 1738, 1699, 1589,
Acknowledgements
1450 cmꢁ1
;
299.0742. Found: 299.0739.
HRMS (FAB+) calcd for C17H15O3S:
We thank the National Institute of General Medical Sciences
(GM72586) for partial support of this research. J.L.M.
thanks GEM, McNair, and the NIH (GM534692—Supple-
ment) for fellowship support. M.S.K. thanks Boehringer
3.2.2.4. 2-Methoxycarbonylmethyl-3-oxo-2,3-dihydro-
benzo[b]thiophene-2-carboxylic acid methyl ester (19).